Literature DB >> 4266421

Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition.

M B Bernik.   

Abstract

Lysis of fibrin in tissue culture has been shown to be due to plasminogen activator identified immunologically as urokinase. The present study examines fibrinolytic events in culture, particularly mechanisms leading to increased urokinase levels and accelerated fibrinolysis. Deposition of fibrin on cells in culture was followed by a two- to six-fold increase in urokinase in the supernates and rapid disappearance of the fibrin. Investigation of factors that might be responsible for these events (including fibrin, fibrinogen, vasoactive stimuli, and the enzymes thrombin and plasmin) indicated that the enhanced urokinase yields were mediated through plasmin and thrombin. Study of the possible modes of action of thrombin and plasmin indicated that these enzymes are capable of acting on the cells themselves as well as on cell-produced material. The effect on cells was manifested by mitotic activity or, occasionally, cell injury and death. Although these effects influenced urokinase levels, enhanced yields were explained best by the action of enzymes on cellproduced material. Studies with plasmin and thrombin, and also trypsin, indicated that proteolytic enzymes may act in various ways-affect the stability of urokinase, interfere with inhibition of urokinase by naturally occurring inhibitor(s), and induce urokinase activity from inactive material. Plasma and thrombin appeared to act primarily through the latter mechanism. Inactive material, which gave rise to urokinase upon exposure to proteolytic enzymes and which may represent urokinase precursor, was found in cultures of kidney, lung, spleen, and thyroid. Urokinase in such inactive state appears to be readily accessible to activation by enzymes, particularly plasmin and thrombin, thus facilitating removal of fibrin and possibly also providing pathways to excessive fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4266421      PMCID: PMC302329          DOI: 10.1172/JCI107246

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Thrombin-E as a fibrinolytic enzyme.

Authors:  W H SEEGERS; R H LANDABURU; J F JOHNSON
Journal:  Science       Date:  1960-03-11       Impact factor: 47.728

2.  The acetylation of thrombin.

Authors:  R H LANDABURU; W H SEEGERS
Journal:  Can J Biochem Physiol       Date:  1959-11

3.  Interaction of thrombin and fibrinogen.

Authors:  L LORAND
Journal:  Physiol Rev       Date:  1954-10       Impact factor: 37.312

4.  Split products of fibrinogen after prolonged interaction with plasmin.

Authors:  J E Niléhn
Journal:  Thromb Diath Haemorrh       Date:  1967-08-15

5.  Effects of Ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity.

Authors:  S Silberman; M B Bernik; E V Potter; H C Kwaan
Journal:  Br J Haematol       Date:  1973-01       Impact factor: 6.998

Review 6.  Blood coagulation and fibrinolysis in tissue culture and tissue repair.

Authors:  T Astrup
Journal:  Biochem Pharmacol       Date:  1968-03       Impact factor: 5.858

7.  Anticoagulants produced by thrombin from fibrin, the effect on blood coagulation, some physical characteristics.

Authors:  C R Muirhead; D C Triantaphyllopoulos
Journal:  Thromb Diath Haemorrh       Date:  1971-10-31

8.  Formation of anticoagulants by digesting fibrin with thrombin.

Authors:  D C Triantaphyllopoulos; C R Muirhead
Journal:  Thromb Diath Haemorrh       Date:  1968-07-31

Review 9.  Bleeding due to increased intravascular blood coagulation. Hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption-coagulopathies).

Authors:  F Rodríguez-Erdmann
Journal:  N Engl J Med       Date:  1965-12-16       Impact factor: 91.245

10.  Enhancement of fibrinolysis and thrombolysis by polysorbate 80 (tween 80).

Authors:  H C Kwaan; P Brakman; T Astrup
Journal:  Experientia       Date:  1967-04-15
View more
  11 in total

1.  Fibrinolytic enzymes in ascites during experimental acute pancreatitis in rats.

Authors:  Y Etoh; H Sumi; H Tsushima; M Maruyama; H Mihara
Journal:  Int J Pancreatol       Date:  1992-10

Review 2.  Translational initiatives in thrombolytic therapy.

Authors:  Melvin E Klegerman
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

3.  Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.

Authors:  V Gurewich; R Pannell; S Louie; P Kelley; R L Suddith; R Greenlee
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

4.  Inflammatory sequences in acute pulmonary radiation injury.

Authors:  D O Slauson; F F Hahn; S A Benjamin; T L Chiffelle; R K Jones
Journal:  Am J Pathol       Date:  1976-03       Impact factor: 4.307

Review 5.  Physiology and pathophysiology of the plasminogen system in the kidney.

Authors:  Per Svenningsen; Gitte Rye Hinrichs; Rikke Zachar; Rikke Ydegaard; Boye L Jensen
Journal:  Pflugers Arch       Date:  2017-06-27       Impact factor: 3.657

6.  A Double-Blind Multicenter Comparison of the Efficacy and Safety of Saruplase and Urokinase in the Treatment of Acute Myocardial Infarction: Report of the SUTAMI Study Group.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

7.  Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin.

Authors:  G A de Munk; E Groeneveld; D C Rijken
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  High expression vectors for the production of recombinant single-chain urinary plasminogen activator from Escherichia coli.

Authors:  R Brigelius-Flohé; G Steffens; W Strassburger; L Flohé
Journal:  Appl Microbiol Biotechnol       Date:  1992-02       Impact factor: 4.813

Review 9.  Fibrinolytic Enzymes for Thrombolytic Therapy.

Authors:  Swaroop S Kumar; Abdulhameed Sabu
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

10.  Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.

Authors:  D L Eaton; J B Baker
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.